Yongqing Yang, Mengyuan Xiao, Jim Lau, Mike Knierman, Hui Zhao, Xi Qiu, Karen Luo, John Sausen, Harsha P. Gunawardena* and Hao Chen*,
{"title":"fc沉默突变抗体的超快微滴消化","authors":"Yongqing Yang, Mengyuan Xiao, Jim Lau, Mike Knierman, Hui Zhao, Xi Qiu, Karen Luo, John Sausen, Harsha P. Gunawardena* and Hao Chen*, ","doi":"10.1021/acs.analchem.5c01856","DOIUrl":null,"url":null,"abstract":"<p >Many novel therapeutic monoclonal antibody (mAb) modalities contain mutations that not only silence unwanted binding to Fc-gamma receptors but also could bring resistance to IdeS enzymatic cleavage into mAb subunits, limiting the antibody middle-down analysis by mass spectrometry (MS). Herein we showed, for the first time, the efficient, reproducible, and ultrafast microdroplet digestion (less than 1 ms) of mAbs carrying a series of mutations “LALA”, “LAGA”, and “LFLE” (e.g., tool antibody LALA-DS, Nivolumab, Pembrolizumab, Vedolizumab, and PD-L1), by a new enzyme: FabRICATOR Xtra (Xtra). The digestion took place during the spray ionization process using an Agilent jet stream (AJS) ion source with a digestion efficiency close to or more than 80%, leading to subunits with high ion abundances for identification and characterization. Increased enzyme/antibody ratio or partial reduction of disulfide bonds increased the digestion efficiency. “One-pot” disulfide reduction and digestion in microdroplets could occur simultaneously by spraying the antibody and enzyme along with the reductant. Notably, for the highly digestion-resistant PD-L1 antibody, the Xtra-based microdroplet digestion process was found to be 9 million times faster than in-solution digestion. Furthermore, a workflow was developed, using a script that can automatically choose a preferred enzyme (Xtra or IdeS) for digestion, based on a target antibody input sequence, which allowed quick analysis of 94 antibody samples within 104 min. Our method is a fully automated microdroplet protein digestion technique that integrates flow injection (FI) and online MS analysis, providing a rapid and robust method for the structural characterization of mAbs with mutations.</p>","PeriodicalId":27,"journal":{"name":"Analytical Chemistry","volume":"97 24","pages":"12813–12823"},"PeriodicalIF":6.7000,"publicationDate":"2025-05-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Ultrafast Microdroplet Digestion of Antibodies with Fc-Silencing Mutations\",\"authors\":\"Yongqing Yang, Mengyuan Xiao, Jim Lau, Mike Knierman, Hui Zhao, Xi Qiu, Karen Luo, John Sausen, Harsha P. Gunawardena* and Hao Chen*, \",\"doi\":\"10.1021/acs.analchem.5c01856\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p >Many novel therapeutic monoclonal antibody (mAb) modalities contain mutations that not only silence unwanted binding to Fc-gamma receptors but also could bring resistance to IdeS enzymatic cleavage into mAb subunits, limiting the antibody middle-down analysis by mass spectrometry (MS). Herein we showed, for the first time, the efficient, reproducible, and ultrafast microdroplet digestion (less than 1 ms) of mAbs carrying a series of mutations “LALA”, “LAGA”, and “LFLE” (e.g., tool antibody LALA-DS, Nivolumab, Pembrolizumab, Vedolizumab, and PD-L1), by a new enzyme: FabRICATOR Xtra (Xtra). The digestion took place during the spray ionization process using an Agilent jet stream (AJS) ion source with a digestion efficiency close to or more than 80%, leading to subunits with high ion abundances for identification and characterization. Increased enzyme/antibody ratio or partial reduction of disulfide bonds increased the digestion efficiency. “One-pot” disulfide reduction and digestion in microdroplets could occur simultaneously by spraying the antibody and enzyme along with the reductant. Notably, for the highly digestion-resistant PD-L1 antibody, the Xtra-based microdroplet digestion process was found to be 9 million times faster than in-solution digestion. Furthermore, a workflow was developed, using a script that can automatically choose a preferred enzyme (Xtra or IdeS) for digestion, based on a target antibody input sequence, which allowed quick analysis of 94 antibody samples within 104 min. Our method is a fully automated microdroplet protein digestion technique that integrates flow injection (FI) and online MS analysis, providing a rapid and robust method for the structural characterization of mAbs with mutations.</p>\",\"PeriodicalId\":27,\"journal\":{\"name\":\"Analytical Chemistry\",\"volume\":\"97 24\",\"pages\":\"12813–12823\"},\"PeriodicalIF\":6.7000,\"publicationDate\":\"2025-05-29\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Analytical Chemistry\",\"FirstCategoryId\":\"92\",\"ListUrlMain\":\"https://pubs.acs.org/doi/10.1021/acs.analchem.5c01856\",\"RegionNum\":1,\"RegionCategory\":\"化学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"CHEMISTRY, ANALYTICAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Analytical Chemistry","FirstCategoryId":"92","ListUrlMain":"https://pubs.acs.org/doi/10.1021/acs.analchem.5c01856","RegionNum":1,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CHEMISTRY, ANALYTICAL","Score":null,"Total":0}
Ultrafast Microdroplet Digestion of Antibodies with Fc-Silencing Mutations
Many novel therapeutic monoclonal antibody (mAb) modalities contain mutations that not only silence unwanted binding to Fc-gamma receptors but also could bring resistance to IdeS enzymatic cleavage into mAb subunits, limiting the antibody middle-down analysis by mass spectrometry (MS). Herein we showed, for the first time, the efficient, reproducible, and ultrafast microdroplet digestion (less than 1 ms) of mAbs carrying a series of mutations “LALA”, “LAGA”, and “LFLE” (e.g., tool antibody LALA-DS, Nivolumab, Pembrolizumab, Vedolizumab, and PD-L1), by a new enzyme: FabRICATOR Xtra (Xtra). The digestion took place during the spray ionization process using an Agilent jet stream (AJS) ion source with a digestion efficiency close to or more than 80%, leading to subunits with high ion abundances for identification and characterization. Increased enzyme/antibody ratio or partial reduction of disulfide bonds increased the digestion efficiency. “One-pot” disulfide reduction and digestion in microdroplets could occur simultaneously by spraying the antibody and enzyme along with the reductant. Notably, for the highly digestion-resistant PD-L1 antibody, the Xtra-based microdroplet digestion process was found to be 9 million times faster than in-solution digestion. Furthermore, a workflow was developed, using a script that can automatically choose a preferred enzyme (Xtra or IdeS) for digestion, based on a target antibody input sequence, which allowed quick analysis of 94 antibody samples within 104 min. Our method is a fully automated microdroplet protein digestion technique that integrates flow injection (FI) and online MS analysis, providing a rapid and robust method for the structural characterization of mAbs with mutations.
期刊介绍:
Analytical Chemistry, a peer-reviewed research journal, focuses on disseminating new and original knowledge across all branches of analytical chemistry. Fundamental articles may explore general principles of chemical measurement science and need not directly address existing or potential analytical methodology. They can be entirely theoretical or report experimental results. Contributions may cover various phases of analytical operations, including sampling, bioanalysis, electrochemistry, mass spectrometry, microscale and nanoscale systems, environmental analysis, separations, spectroscopy, chemical reactions and selectivity, instrumentation, imaging, surface analysis, and data processing. Papers discussing known analytical methods should present a significant, original application of the method, a notable improvement, or results on an important analyte.